Search results
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
Motley Fool· 2 years agoThe pharmaceutical industry is fraught with risk and also filled with opportunity. On one hand, the...
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
Motley Fool· 2 years agoA recent poll on prescription drug prices found that 83% of Americans view prescription drug prices...
Here's What is Driving Amgen (AMGN) Stock's Outperformance
Zacks via Yahoo Finance· 1 year agoAmgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the...
Roche's (RHHBY) Application for PNH Drug Accepted by FDA
Zacks via Yahoo Finance· 8 months agoRoche Group RHHBY member Genentech has received a significant boost following the acceptance of its...
3 No-Brainer Stocks to Buy With $400 Right Now
Motley Fool· 1 year agoAs 2022 reminded the investing community, the stock market doesn't move up in a straight line. When the curtain closed, the Dow Jones Industrial Average,...
Platinum, Gold and More of the Most Valuable Substances in the World
GoBankingRates via AOL· 2 years agoRare and beautiful items have always had a grip on the imagination--and finances--of humankind....
Novartis says operating profit to grow again ahead of Sandoz spin-off
Reuters via Yahoo Finance· 1 year agoNovartis on Wednesday predicted that core operating income would grow in a "mid single digit"...
AstraZeneca sues US over Medicare drug price negotiation plans
Reuters via Yahoo Finance· 8 months agoThe British drugmaker, which filed its complaint in a Delaware district court, joins other...
3 Nasdaq 100 Stocks That Are Surefire Buys in June
Motley Fool· 11 months agoIt's been an interesting past two years for Wall Street. In 2021, the major U.S. stock indexes could do no wrong and hit multiple new all-time highs....
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...